 |
 |
|
Today is Thursday, November 20, 2008 |
|
|
When this edition of Words To Live By was originally published, the links below opened active web pages. |
|
News HeadlinesCombination of Implants Benefits Patients with Recurrent Glioblastoma Minimally Invasive Methods Allow Near-Complete Lung Cancer Staging Survival Benefit Seen with Radiation Therapy in Early Pancreatic Cancer Deforolimus Shows Activity Against Advanced Solid Tumors Chemotherapy Can Restore Endocrine Sensitivity in Prostate Cancer Male Patients with Hodgkin Lymphoma Face High Risk of Infertility Cuts in Government Spending in Basic Science and Medicine in 2008 Budget Cancerpage news is updated daily, Monday through Friday, and on the weekends as warranted. Twenty-one new articles have been added to cancerpage news since the last newsletter. To see ALL the latest stories, go to the cancerpage.com search page and click on Submit (but leave search field black.)
FDA Recalls Infusion Pump
FDA issued a Class I Recall of Medtronic Inc, SynchroMed EL Implantable
Infusion Pump Models 8626-10, 8626L-10, 8626-18, 8626L-18, 8627-10, 8627L-10, 8627-18,
and 8627L-18. The device administers drugs to a specific site in the body to treat pain,
cancer, and other conditions. It was recalled because the pump could stall and
stop without warning. The recall covers pumps manufactured before September
1999. Questions? Call Medtronic Neuromodulation Patient Services at 1-800-510-6735.
More information is available at the FDA website
here.
A Class I Recall is the
most serious type of recall. because it can cause a serious health problem
or death.
Stand Up
For A Cure Assessing the Risk Don't panic, not everything causes cancer.
Researchers in Australia have come up with a new type of cancer assessment tool
that they argue gives a more realistic view of the cancer risk posed by the
world around us. They look at more than 60 different situation ranging from
cigarette smoking (yes, it's the most dangerous) to underarm deodorants (way
overblown risk!) Their research was releases in conjunction with World
Cancer day last Monday. You can read about the risk scale
here.
Call for
Entries - Oncology Nursing Awards CURE magazine is taking nominations for its 2008 Extraordinary Healer
Award for Oncology Nursing. The award honors "one of the thousands of
exceptional oncology nurses who demonstrate daily their
unwavering dedication, compassion and helpfulness."
Last year more than 200 cancer patients and survivors nominated nurses for the honor.
Nominations must be received by April 7, 2008. For more information about the 2008 Extraordinary Healer Award for Oncology Nursing, visit
www.curetoday.com.
HPV and
Oral Cancer A study published in the Journal of Clinical
Oncology this week could fuel talk about whether boys should be vaccinated against
the human papilloma virus. While HPV has been linked to some head and neck
cancers, it's not known if the vaccination that is now recommended for young
girls to protect them against HPV infection and cervical cancer would also
protect against other HPV-linked cancers that are sexually transmitted. Read
more about it
here.
Pediatric
Phase III FAP Clinical Trial The drug giant Pfizer wants to see if the drug celecoxib will
reduce or prevent colon polyp formation in children aged 10-17 who carry the
gene for Familial Adenomatous Polyposis. People with that genetic mutation
have a high risk of developing colon cancer. Pfizer is currently recruiting for
the clinical trial. You can find more information about the double blind placebo
controlled trial
here. |
![[standforcure 2008]](/newsletter/images/standforcure2008.jpg)
|
The weekly cancerpage.com newsletter,
Words To Live By, is intended for educational purposes only.
|
![[close window]](/images/buttons/close.gif)